|

pH Low Insertion Peptide-exatecan Conjugate CBX-12 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Alphalex Conjugate CBX-12, Alphalex-exatecan Conjugate CBX-12, CBX 12, CBX-12, CBX12 +2 more

Pipeline

Phase 1: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Metastatic Malignant Solid Neoplasm1
  • Advanced Malignant Solid Neoplasm1
  • Cancer1

Bethesda, Maryland1 trial

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

National Cancer Institute Developmental Therapeutics Clinic

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.